Loading...
MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity
OBJECTIVE: To isolate and characterize muscle-specific kinase (MuSK) monoclonal antibodies from patients with MuSK myasthenia gravis (MG) on a genetic and functional level. METHODS: We generated recombinant MuSK antibodies from patient-derived clonal MuSK-specific B cells and produced monovalent Fab...
Na minha lista:
| Udgivet i: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams & Wilkins
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6410930/ https://ncbi.nlm.nih.gov/pubmed/30882021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000547 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|